Toru Mori

Author PubWeight™ 34.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis. Trop Med Int Health 2010 2.35
2 Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol 2006 2.06
3 Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006 1.74
4 Advances in the diagnosis of tuberculosis. Respirology 2010 1.50
5 Challenges to the global control of tuberculosis. Respirology 2013 1.40
6 Correlation between suspended particles in the environmental air and causes of disease among inhabitants: cross-sectional studies using the vital statistics and air pollution data in Japan. Environ Res 2005 1.38
7 Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis. Respirology 2008 1.26
8 Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains. J Clin Microbiol 2007 1.22
9 Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect 2008 1.13
10 Use of QuantiFERON-TB Gold to investigate tuberculosis contacts in a high school. Respirology 2007 1.12
11 Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis. Tuberculosis (Edinb) 2008 1.07
12 [Basic characteristics of a novel diagnostic method (QuantiFERON TB-2G) for latent tuberculosis infection with the use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10]. Kekkaku 2004 1.03
13 A revaluation of folliculosebaceous cystic hamartoma: the histopathological and immunohistochemical features. Am J Dermatopathol 2010 0.99
14 Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2010 0.99
15 A revaluation of trichofolliculoma: the histopathological and immunohistochemical features. Am J Dermatopathol 2010 0.96
16 Computerized surveillance system of tuberculosis in Japan: its evolution, achievement and challenges. Kekkaku 2012 0.94
17 Diagnosis of active tuberculous serositis by antigen-specific interferon-gamma response of cavity fluid cells. Clin Infect Dis 2007 0.93
18 Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol 2011 0.90
19 Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2012 0.89
20 [Usefulness of QuantiFERON TB-2G in contact investigation of a tuberculosis outbreak in a university]. Kekkaku 2005 0.88
21 Evaluation of a line probe assay for the rapid detection of gyrA mutations associated with fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis. J Med Microbiol 2010 0.86
22 Performance of a Whole-Blood Interferon-Gamma Release Assay with Mycobacterium RD1-Specific Antigens among HIV-Infected Persons. Clin Dev Immunol 2010 0.85
23 Evaluation of major membrane protein-II as a tool for serodiagnosis of leprosy. FEMS Microbiol Lett 2007 0.82
24 [Variation in yield of needle scars with multipuncture BCG vaccination]. Nihon Koshu Eisei Zasshi 2005 0.82
25 Comparison of performance in two diagnostic methods for tuberculosis infection. Med Microbiol Immunol 2008 0.80
26 Transmission of specific genotype streptomycin resistant strains of Mycobacterium tuberculosis in the Tokyo Metropolitan Area in Japan. BMC Infect Dis 2009 0.80
27 [Effects of prophylaxis on QuantiFERON TB-2G responses among children]. Kekkaku 2008 0.79
28 [Frequency of MDR-TB/XDR-TB strains isolated from chronic pulmonary tuberculosis patients in Japan]. Kekkaku 2007 0.79
29 [Utility of QuantiFERON TB-2G for tuberculosis contact investigations in public health services]. Nihon Koshu Eisei Zasshi 2007 0.78
30 Analysis of an interferon-gamma release assay for monitoring the efficacy of anti-tuberculosis chemotherapy. Jpn J Infect Dis 2011 0.77
31 Pulmonary hilar lymph nodes in lung cancer: assessment with 3D-dynamic contrast-enhanced MR imaging. Eur J Radiol 2003 0.76
32 [Usefulness of a novel diagnostic method of tuberculosis infection, QuantiFERON TB-2G, in an outbreak of tuberculosis]. Kekkaku 2004 0.76
33 Microepidemics of tuberculosis revealed by DNA-fingerprinting of M. tuberculosis. Intern Med 2004 0.75
34 [Progress in the field of pulmonary medicine in the last 100 years: Mass screening for tuberculosis]. Nihon Naika Gakkai Zasshi 2002 0.75
35 Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data. Endocr J 2005 0.75
36 [Analysis of tuberculosis infection among foreigners using QuantiFeron TB-2G test]. Kekkaku 2007 0.75
37 [A survey on the onset of tuberculosis in nursing homes]. Kekkaku 2003 0.75
38 [Comparison of conventional tuberculin skin test and QFT-2G, a new method for diagnosis of tuberculosis infection, with the use of the contact score]. Kekkaku 2011 0.75
39 [Considerations on uses of newly developed anti-tuberculosis drugs for multi-drug resistant tuberculosis]. Kekkaku 2014 0.75
40 [Detection of tuberculosis infection using a whole blood interferon gamma assay in a contact investigation--evaluation using quantiFERon TB-2G]. Kekkaku 2005 0.75
41 Accuracy of LAMP-TB Method for Diagnosing Tuberculosis in Haiti. Jpn J Infect Dis 2016 0.75
42 [Relationship between BCG immunization coverage and the immunization delivery system in the Tama area of Tokyo]. Kansenshogaku Zasshi 2012 0.75
43 [Tuberculosis in the patients undergoing haemodialysis in Japan, 1996]. Kekkaku 2002 0.75
44 [Prevention of nosocomial infection of tuberculosis]. Nihon Rinsho 2003 0.75
45 [Investigation on preventive measures of tuberculosis infection and onset of tuberculosis in nursing homes for the aged]. Kekkaku 2002 0.75
46 Congenital myofibroma of the skin mimicking a piloleiomyoma. J Cutan Pathol 2009 0.75
47 Assessment of nosocomial transmission of tuberculosis in a psychiatric hospital using a whole blood interferon-gamma assay. Jpn J Infect Dis 2008 0.75
48 [A new anti-mycobacterial agent, rifabutin]. Kekkaku 2010 0.75
49 [Contact investigation using QuantiFERON-TB Gold test to evaluate TB exposure in 61 subjects in a hospital setting--(2) Change in QuantiFERON response during one year after exposure]. Kekkaku 2013 0.75
50 Survey of human immunodeficiency virus (HIV)-seropositive patients with mycobacterial infection in Japan. J Infect 2005 0.75
51 [The East Japan Earthquake and tsunami disaster and tuberculosis]. Kekkaku 2011 0.75
52 [Contact investigation using QuantiFERON-TB Gold test to evaluate TB exposure in 61 subjects in a hospital setting--(1) Outline of the outbreak and its clinical picture]. Kekkaku 2012 0.75
53 [NINETY YEARS OF THE JAPANESE SOCIETY FOR TUBERCULOSIS--Back to the Future for Research and Control of Tuberculosis]. Kekkaku 2015 0.75
54 [The present situation of daily life of tuberculosis patients treated in hospitals with beds for tuberculosis in Japan]. Kekkaku 2002 0.75
55 Evaluation of a 1 step TRAb assay for the detection of high-affinity components to hTSHR: evidences indicating superiority of the assay in the lower TRAb range. Endocr J 2006 0.75
56 [Results of repeated QFT-2G checkings at two-year interval and their comparison with TST results introduced into infection control program for staffs working at a hospital with isolation wards for tuberculosis]. Kekkaku 2008 0.75
57 [Usefulness of QuantiFERONTB-2G in a suspected case of drug resistant tuberculosis outbreak in a university]. Kekkaku 2008 0.75